The effect of zoledronic acid on aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: the Z-FAST study 36-month follow-up

被引：0
|
作者：
Brufsky, A. [1 ]
Bosserman, L. [1 ]
Caradonna, R. [1 ]
Haley, B. [1 ]
Jones, M. [1 ]
Moore, H. [1 ]
Doug, M. [1 ]
Warsi, G. [1 ]
Lacerna, L. [1 ]
Perez, E. [1 ]
机构：
[1] Novartis Pharmaceut, E Hanover, NJ USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S8 / S9
页数：2
相关论文
共 50 条
  • [1] Zoledronic Acid Effectively Prevents Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST Study 36-Month Follow-up Results
    Brufsky, Adam M.
    Bosserman, Linda D.
    Caradonna, Richard R.
    Haley, Barbara B.
    Jones, Michael
    Moore, Halle C. F.
    Jin, Lixian
    Warsi, Ghulam M.
    Ericson, Solveig G.
    Perez, Edith A.
    [J]. CLINICAL BREAST CANCER, 2009, 9 (02) : 77 - 85
  • [2] The Effect of Zoledronic Acid on Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: The Z-FAST study 5-Year Final Follow-Up
    Brufsky, A.
    Harker, G.
    Beck, J. T.
    Carroll, R.
    Jin, L.
    Warsi, G.
    Argonza-Aviles, E.
    Ericson, S.
    Perez, E. A.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 733S - 734S
  • [3] Zoledronic acid (ZA) prevents aromatase inhibitor (AI)-associated bone loss in postmenopausal women with early breast cancer 36-month follow-up of the Z-FAST study
    Brufsky, A.
    Bosserman, L.
    Caradonna, R.
    Haley, B.
    Jones, M.
    Moore, H.
    Dong, M.
    Warsi, G.
    Ericson, S.
    Perez, E.
    [J]. EJC SUPPLEMENTS, 2008, 6 (07): : 197 - 197
  • [4] The effect of zoledronic acid on aromatase inhibitor associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36 months follow-up of ZO-FAST
    Eidtmann, H.
    Bundred, N. J.
    DeBoer, R.
    Llombart, A.
    Davidson, N.
    Neven, P.
    von, Minckwitz G.
    Miller, J.
    Schenk, A.
    Coleman, R.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 74S - 74S
  • [5] Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole
    Bundred, Nigel J.
    Campbell, Ian D.
    Davidson, Neville
    DeBoer, Richard H.
    Eidtmann, Holger
    Monnier, Alain
    Neven, Patrick
    von Minckwitz, Gunter
    Miller, Joel C.
    Schenk, Nora L.
    Coleman, Robert E.
    [J]. CANCER, 2008, 112 (05) : 1001 - 1010
  • [6] Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole
    Brufsky, Adam
    Bundred, Nigel
    Coleman, Robert
    Lambert-Falls, Rosemary
    Mena, Raul
    Hadji, Peyman
    Jin, Lixian
    Schenk, Nora
    Ericson, Solveig
    Perez, Edith A.
    [J]. ONCOLOGIST, 2008, 13 (05): : 503 - 514
  • [7] Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole
    Sun, Shengliang
    Wang, Fuchao
    Dou, Honglei
    Zhang, Longqiang
    Li, Jiwen
    [J]. ONCOTARGETS AND THERAPY, 2016, 9 : 6029 - 6036
  • [8] The protective effect of zoledronic acid on bone loss in postmenopausal women with early breast cancer treated with sequential tamoxifen and letrozole: 36-month follow-up
    Greenberg, J.
    Stemmer, S. M.
    Bernstein-Molho, R.
    Pelles-Avraham, S.
    Stephansky, I.
    Inbar, M. J.
    Geffen, D. B.
    Safra, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] THE EFFECT OF ZOLEDRONIC ACID ON AROMATASE INHIBITOR (AI) ASSOCIATED BONE LOSS (AIBL) IN POSTMENOPAUSAL WOMEN (PMW) WITH EARLY BREAST CANCER (EBC) RECEIVING ADJUVANT LETROZOLE: 24 MONTHS (MOS) INTEGRATED FOLLOW-UP OF THE Z-FAST/ZO-FAST TRIALS
    Frassoldati, A.
    Brufsky, A.
    Bundred, N.
    Lambert-Falls, R.
    Hadji, P.
    Mena, R.
    Paija, O.
    Coleman, R.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 78 - 78
  • [10] The Effect of Zoledronic Acid on Aromatase Inhibitor Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: The ZO-FAST Study 5-Year Final Follow-Up
    DeBoer, R.
    Bundred, N.
    Eidtmann, H.
    Llombert, A.
    Neven, P.
    von Minckwitz, G.
    Martin, N.
    Modi, A.
    Coleman, R.
    [J]. CANCER RESEARCH, 2010, 70
12345